[1]
|
Owens, D.M., Nelson, D.K. and Talley, N.J. (1995) The irritable bowel syndrome: Long-term prognosis and the physician-patient interaction. Annals of Internal Medicine, 122, 107-112.
doi:10.7326/0003-4819-122-2-199501150-00005
|
[2]
|
Hahn, B.A., Yan, S. and Strassels, S. (1999) Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion, 60, 77-81. doi:10.1159/000007593
|
[3]
|
El-Serag, H.B., Olden, K. and Bjorkman, D. (2002) Health-related quality of life among persons with irritable bowel syndrome: A systematic review. Alimentary Pharmacology & Therapeutics, 16, 1171-1185.
doi:10.1046/j.1365-2036.2002.01290.x
|
[4]
|
Camilleri, M., Northcutt, A.R., Kong, S., Dukes, G.E., McSorley, D. and Mangel, A.W. (2000) Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomised, placebo-controlled trial. Lancet, 355, 1035-1040. doi:10.1016/S0140-6736(00)02033-X
|
[5]
|
Watson, M.E., Lacey, L., Kong, S., Northcutt, A.R., McSorley, D., Hahn, B. and Mangel, A.W. (2001) Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome. The American Journal of Gastroenterology, 96, 455-459.
doi:10.1111/j.1572-0241.2001.03525.x
|
[6]
|
Van, O.M., Mayeur, S., Meeus, M.A., Rosillon, D., Hendrickx, B. and Ceuppens, M. (1995) A double-blind crossover comparison study of the safety and efficacy of mebeverine with mebeverine sustained release in the treatment of irritable bowel syndrome. Journal of Clinical Pharmacy and Therapeutics, 20, 277-282.
doi:10.1111/j.1365-2710.1995.tb00663.x
|
[7]
|
Inauen, W. and Halter, F. (1994) Clinical efficacy, safety and tolerance of mebeverine slow release (200 mg) vs. mebeverine tablets in patients with irritable bowel syndrome. Drug Investigation, 8, 234-240.
doi:10.1007/BF03258483
|
[8]
|
Gilbody, J.S., Fletcher, C.P., Hughes, I.W. and Kidman, S.P. (2000) Comparison of two different formulations of mebeverine hydrochloride in irritable bowel syndrome. International Journal of Clinical Practice, 54, 461-464.
|
[9]
|
Lembo, A.J. (2007) The clinical and economic burden of irritable bowel syndrome. Practical Gastroenterology, 9, 3-9.
|
[10]
|
Cremonini, F. and Talley, N.J. (2005) Irritable bowel syndrome: Epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterology Clinics of North America, 34, 189-204.
doi:10.1016/j.gtc.2005.02.008
|
[11]
|
Talley, N.J. (1999) Irritable bowel syndrome: Definition, diagnosis and epidemiology. Best Practice & Research Clinical Gastroenterology, 13, 371-384.
doi:10.1053/bega.1999.0033
|
[12]
|
Petitpierre, M., Gumowski, P. and Girard, J.P. (1985) Irritable bowel syndrome and hypersensitivity to food. Annals of Allergy, 54, 538-540.
|
[13]
|
Zar, S., Kumar, D. and Benson, M.J. (2001) Food hyper- sensitivity and irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 15, 439-449.
doi:10.1046/j.1365-2036.2001.00951.x
|
[14]
|
Zwetchkenbaum, J.F. and Burakoff, R. (1988) Food allergy and the irritable bowel syndrome. The American Journal of Gastroenterology, 83, 901-904.
|
[15]
|
Awazuhara, H., Kawai, H. and Maruchi, N. (1997) Major allergens in soybean and clinical significance of IgG4 antibodies investigated by IgE- and IgG4-immunoblotting with sera from soybean-sensitive patients. Clinical & Experimental Allergy, 27, 325-332.
doi:10.1111/j.1365-2222.1997.tb00711.x
|
[16]
|
Crowe, S.E. and Perdue, M.H. (1992) Gastrointestinal food hypersensitivity: Basic mechanisms of pathophysiology. Gastroenterology, 103, 1075-1095.
|
[17]
|
elRafei, A., Peters, S.M., Harris, N. and Bellanti, J.A. (1989) Diagnostic value of IgG4 measurements in patients with food allergy. Annals of Allergy, 62, 94-99.
|
[18]
|
Host, A., Husby, S., Gjesing, B., Larsen, J.N. and Low-enstein, H. (1992) Prospective estimation of IgG, IgG subclass and IgE antibodies to dietary proteins in infants with cow milk allergy. Levels of antibodies to whole milk protein, BLG and ovalbumin in relation to repeated milk challenge and clinical course of cow milk allergy. Allergy, 47, 218-229. doi:10.1111/j.1398-9995.1992.tb00654.x
|
[19]
|
Groll, D., Vanner, S.J., Depew, W.T., DaCosta, L.R., Simon, J.B., Groll, A., Roblin, N. and Paterson, W.G. (2002) The IBS-36: A new quality of life measure for irritable bowel syndrome. The American Journal of Gastroenterology, 97, 962-971.
doi:10.1111/j.1572-0241.2002.05616.x
|
[20]
|
Ware, J., Kosinski, M. and Dewey, J. (2000) How to score version two of the sf-36 health survey. Quality Metric, Incorporated, Lincoln, RI.
|
[21]
|
Drisko, J., Bischoff, B., Hall, M. and McCallum, R. (2006) Treating irritable bowel syndrome with a food elimination diet followed by food challenge and probiotics. Journal of the American College of Nutrition, 25, 514-522. doi:10.1080/07315724.2006.10719567
|
[22]
|
Asero, R., Ballmer-Weber, B.K., Beyer, K., Conti, A., Dubakiene, R., Fernandez-Rivas, M., Hoffmann-Sommergruber, K., Lidholm, J., Mustakov, T., Oude Elberink, J.N., Pumphrey, R.S., Stahl, S.P., van, R.R., Vlieg-Boerstra, B.J., Hiller, R., Hourihane, J.O., Kowalski, M., Papadopoulos, N.G., Wal, J.M., Mills, E.N. and Vieths, S. (2007) IgE-mediated food allergy diagnosis: Current status and new perspectives. Molecular Nutrition & Food Research, 51, 135-147. doi:10.1002/mnfr.200600132
|
[23]
|
Ortolani, C., Bruijnzeel-Koomen, C., Bengtsson, U., Bindslev-Jensen, C., Bjorksten, B., Host, A., Ispano, M., Jarish, R., Madsen, C., Nekam, K., Paganelli, R., Poulsen, L.K. and Wuthrich, B. (1999) Controversial aspects of adverse reactions to food. European Academy of Allergology and Clinical Immunology (EAACI) reactions to food subcommittee. Allergy, 54, 27-45.
doi:10.1034/j.1398-9995.1999.00913.x
|
[24]
|
Atkinson, W., Sheldon, T.A., Shaath, N. and Whorwell, P.J. (2004) Food elimination based on IgG antibodies in irritable bowel syndrome: A randomised controlled trial. Gut, 53, 1459-1464. doi:10.1136/gut.2003.037697
|
[25]
|
Husby, S., Oxelius, V.A., Teisner, B., Jensenius, J.C. and Svehag, S.E. (1985) Humoral immunity to dietary antigens in healthy adults. Occurrence, isotype and IgG subclass distribution of serum antibodies to protein antigens. International Archives of Allergy and Immunology, 77, 416-422. doi:10.1159/000233819
|
[26]
|
King, H.C. (1994) Exploring the maze of adverse reactions to foods. Ear, Nose & Throat Journal, 73, 237-241.
|
[27]
|
Kruszewski, J., Raczka, A., Klos, M. and Wiktor-Jedrzejczak, W. (1994) High serum levels of allergen specific IgG-4 (asIgG-4) for common food allergens in healthy blood donors. Archivum Immunologiae et Therapia Experimentalis (Warsz), 42, 259-261.
|
[28]
|
Nanda, R., James, R., Smith, H., Dudley, C.R. and Jewell, D.P. (1989) Food intolerance and the irritable bowel syndrome. Gut, 30, 1099-1104. doi:10.1136/gut.30.8.1099
|
[29]
|
Sicherer, S.H. (2001) Clinical implications of cross-reactive food allergens. Journal of Allergy and Clinical Immunology, 108, 881-890. doi:10.1067/mai.2001.118515
|
[30]
|
Sicherer, S.H. (1999) Food allergy: When and how to perform oral food challenges. Pediatric Allergy and Immunology, 10, 226-234.
doi:10.1034/j.1399-3038.1999.00040.x
|
[31]
|
Gordon, B.R. (2003) Approaches to testing for food and chemical sensitivities. Otolaryngologic Clinics of North America, 36, 917-940.
doi:10.1016/S0030-6665(03)00059-8
|
[32]
|
Sampson, H.A. and Burks, A.W. (1996) Mechanisms of food allergy. Annual Review of Nutrition, 16, 161-177.
doi:10.1146/annurev.nu.16.070196.001113
|